EXR
Price
$155.95
Change
+$0.01 (+0.01%)
Updated
Feb 21 closing price
Capitalization
31.05B
3 days until earnings call
PSA
Price
$304.19
Change
+$0.13 (+0.04%)
Updated
Feb 21 closing price
Capitalization
50.96B
2 days until earnings call
Ad is loading...

EXR vs PSA

Header iconEXR vs PSA Comparison
Open Charts EXR vs PSABanner chart's image
Extra Space Storage
Price$155.95
Change+$0.01 (+0.01%)
Volume$1.12M
Capitalization31.05B
Public Storage
Price$304.19
Change+$0.13 (+0.04%)
Volume$593.16K
Capitalization50.96B
EXR vs PSA Comparison Chart
Loading...
EXR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EXR vs. PSA commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EXR is a Hold and PSA is a Buy.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (EXR: $155.95 vs. PSA: $304.19)
Brand notoriety: EXR and PSA are both not notable
Both companies represent the Real Estate Investment Trusts industry
Current volume relative to the 65-day Moving Average: EXR: 92% vs. PSA: 89%
Market capitalization -- EXR: $31.05B vs. PSA: $50.96B
EXR [@Real Estate Investment Trusts] is valued at $31.05B. PSA’s [@Real Estate Investment Trusts] market capitalization is $50.96B. The market cap for tickers in the [@Real Estate Investment Trusts] industry ranges from $243.79B to $0. The average market capitalization across the [@Real Estate Investment Trusts] industry is $5.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EXR’s FA Score shows that 1 FA rating(s) are green whilePSA’s FA Score has 2 green FA rating(s).

  • EXR’s FA Score: 1 green, 4 red.
  • PSA’s FA Score: 2 green, 3 red.
According to our system of comparison, PSA is a better buy in the long-term than EXR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EXR’s TA Score shows that 5 TA indicator(s) are bullish while PSA’s TA Score has 5 bullish TA indicator(s).

  • EXR’s TA Score: 5 bullish, 4 bearish.
  • PSA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, PSA is a better buy in the short-term than EXR.

Price Growth

EXR (@Real Estate Investment Trusts) experienced а +0.66% price change this week, while PSA (@Real Estate Investment Trusts) price change was +2.28% for the same time period.

The average weekly price growth across all stocks in the @Real Estate Investment Trusts industry was -0.69%. For the same industry, the average monthly price growth was +0.59%, and the average quarterly price growth was -4.12%.

Reported Earning Dates

EXR is expected to report earnings on May 06, 2025.

PSA is expected to report earnings on May 06, 2025.

Industries' Descriptions

@Real Estate Investment Trusts (-0.69% weekly)

A real estate investment trust (REIT) is a company any that owns, and in most cases, operates, income-producing real estate – ranging from office and apartment buildings to warehouses, hospitals, shopping centers, hotels and timberlands. Some REITs are involved in financing real estate. Equity REITs invest in and own properties, while mortgage REITs own and invest in property mortgages. REITs are required by law to pay out at least 90% of their annual taxable income (excluding capital gains) to shareholders in the form of dividends. Some REITs could be more cyclical than others; for example, when an economy is undergoing a recession, hotel REITs could be more vulnerable, compared to say healthcare REIT given that healthcare needs are less likely to depend on economic cycles. American Tower Corporation, Prologis, Inc. and Crown Castle International Corp are some of the biggest REIT companies in the U.S.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PSA($51B) has a higher market cap than EXR($31B). EXR has higher P/E ratio than PSA: EXR (30.96) vs PSA (25.90). EXR YTD gains are higher at: 4.238 vs. PSA (1.586). PSA has higher annual earnings (EBITDA): 3.34B vs. EXR (1.82B). PSA has more cash in the bank: 370M vs. EXR (99.1M). PSA has less debt than EXR: PSA (9.1B) vs EXR (11.3B). PSA has higher revenues than EXR: PSA (4.52B) vs EXR (2.56B).
EXRPSAEXR / PSA
Capitalization31B51B61%
EBITDA1.82B3.34B54%
Gain YTD4.2381.586267%
P/E Ratio30.9625.90120%
Revenue2.56B4.52B57%
Total Cash99.1M370M27%
Total Debt11.3B9.1B124%
FUNDAMENTALS RATINGS
EXR vs PSA: Fundamental Ratings
EXR
PSA
OUTLOOK RATING
1..100
1326
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
91
Overvalued
PROFIT vs RISK RATING
1..100
4937
SMR RATING
1..100
8131
PRICE GROWTH RATING
1..100
5757
P/E GROWTH RATING
1..100
1628
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EXR's Valuation (85) in the Real Estate Investment Trusts industry is in the same range as PSA (91). This means that EXR’s stock grew similarly to PSA’s over the last 12 months.

PSA's Profit vs Risk Rating (37) in the Real Estate Investment Trusts industry is in the same range as EXR (49). This means that PSA’s stock grew similarly to EXR’s over the last 12 months.

PSA's SMR Rating (31) in the Real Estate Investment Trusts industry is somewhat better than the same rating for EXR (81). This means that PSA’s stock grew somewhat faster than EXR’s over the last 12 months.

PSA's Price Growth Rating (57) in the Real Estate Investment Trusts industry is in the same range as EXR (57). This means that PSA’s stock grew similarly to EXR’s over the last 12 months.

EXR's P/E Growth Rating (16) in the Real Estate Investment Trusts industry is in the same range as PSA (28). This means that EXR’s stock grew similarly to PSA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EXRPSA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
52%
Bearish Trend 2 days ago
48%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
69%
MACD
ODDS (%)
Bullish Trend 3 days ago
70%
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 2 days ago
63%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 2 days ago
61%
Advances
ODDS (%)
Bullish Trend 12 days ago
70%
Bullish Trend 2 days ago
61%
Declines
ODDS (%)
Bearish Trend 19 days ago
63%
Bearish Trend 5 days ago
56%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
54%
Bearish Trend 2 days ago
35%
Aroon
ODDS (%)
Bullish Trend 3 days ago
64%
Bullish Trend 2 days ago
52%
View a ticker or compare two or three
Ad is loading...
EXR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SYNA75.491.92
+2.61%
Synaptics
RTO26.18-0.25
-0.95%
Rentokil Initial plc
DSP22.28-0.45
-1.98%
Viant Technology
OLB1.30-0.04
-2.69%
OLB Group Inc. (The)
CATX2.84-0.08
-2.74%
Perspective Therapeutics